Spotlighting cellular therapies to advance the treatment of medulloblastoma.
作者信息
Ligon John A, Sayour Elias J
机构信息
Department of Pediatrics, Division of Hematology/Oncology, University of Florida, Gainesville, FL, USA.
Department of Neurosurgery, University of Florida, Preston A. Wells, Jr. Center for Brain Tumor Therapy, Gainesville, FL, USA.
出版信息
Neuro Oncol. 2023 Apr 6;25(4):628-630. doi: 10.1093/neuonc/noad005.
Abstract
摘要
相似文献
1
Spotlighting cellular therapies to advance the treatment of medulloblastoma.聚焦细胞疗法以推进髓母细胞瘤的治疗。
Neuro Oncol. 2023 Apr 6;25(4):628-630. doi: 10.1093/neuonc/noad005.
2
Medulloblasoma: challenges for effective immunotherapy.髓母细胞瘤：免疫治疗的挑战。
J Neurooncol. 2012 May;108(1):1-10. doi: 10.1007/s11060-011-0776-1. Epub 2011 Dec 16.
3
Oncogenic role of cytomegalovirus in medulloblastoma?巨细胞病毒在髓母细胞瘤中的致癌作用？
Cancer Lett. 2017 Nov 1;408:55-59. doi: 10.1016/j.canlet.2017.08.024. Epub 2017 Aug 24.
4
Medulloblastoma: an Old Diagnosis with New Promises.髓母细胞瘤：旧诊断带来新希望。
Curr Oncol Rep. 2020 Jul 9;22(9):90. doi: 10.1007/s11912-020-00953-4.
5
Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma.从寒冷中归来：克服髓母细胞瘤的敌对免疫微环境。
Genes Dev. 2022 May 1;36(9-10):514-532. doi: 10.1101/gad.349538.122.
6
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.分子肿瘤学时代成人髓母细胞瘤治疗的新视角。
Crit Rev Oncol Hematol. 2015 Jun;94(3):348-59. doi: 10.1016/j.critrevonc.2014.12.016. Epub 2014 Dec 31.
7
An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK).采用淋巴因子激活的杀伤细胞（LAK）对髓母细胞瘤患者进行过继性免疫治疗。
Acta Neurochir (Wien). 1988;94(1-2):47-52. doi: 10.1007/BF01406615.
8
Medulloblastoma--caution regarding new treatment approaches.髓母细胞瘤——关于新治疗方法的注意事项。
Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):897-9. doi: 10.1016/0360-3016(91)90038-6.
9
Medulloblastoma.髓母细胞瘤
Eur J Cancer. 2011 Sep;47 Suppl 3:S338. doi: 10.1016/S0959-8049(11)70194-0.
10
Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.通过基因组学定制髓母细胞瘤治疗方案：一次一个亚组进行改变。
Annu Rev Genomics Hum Genet. 2017 Aug 31;18:143-166. doi: 10.1146/annurev-genom-091416-035434. Epub 2017 May 5.
引用本文的文献
1
Therapeutic approaches for targeting the pediatric brain tumor microenvironment.针对小儿脑肿瘤微环境的治疗方法。
Drug Deliv Transl Res. 2025 Apr 21. doi: 10.1007/s13346-025-01839-3.
2
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.INSPIRED 研讨会第 4B 部分：嵌合抗原受体 T 细胞相关研究——既定发现和未来重点。
Transplant Cell Ther. 2024 Feb;30(2):155-170. doi: 10.1016/j.jtct.2023.10.012. Epub 2023 Oct 18.
本文引用的文献
1
Cellular immunotherapy for medulloblastoma.用于髓母细胞瘤的细胞免疫疗法。
Neuro Oncol. 2023 Apr 6;25(4):617-627. doi: 10.1093/neuonc/noac236.
2
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions.儿童和青年实体瘤的过继细胞治疗：现状与未来方向。
Front Immunol. 2022 Feb 22;13:846346. doi: 10.3389/fimmu.2022.846346. eCollection 2022.
3
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.用于 H3K27M 突变型弥漫性中线脑胶质瘤的 GD2-CAR T 细胞疗法。
Nature. 2022 Mar;603(7903):934-941. doi: 10.1038/s41586-022-04489-4. Epub 2022 Feb 7.
4
The current landscape of immunotherapy for pediatric brain tumors.儿童脑肿瘤免疫治疗的现状。
Nat Cancer. 2022 Jan;3(1):11-24. doi: 10.1038/s43018-021-00319-0. Epub 2022 Jan 20.
5
Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen.弥合婴儿髓母细胞瘤治疗差距：一种全球可行方案的分子信息预后结果。
Neuro Oncol. 2020 Dec 18;22(12):1873-1881. doi: 10.1093/neuonc/noaa122.
6
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.靶向谷氨酰胺代谢通过调节抑制性髓系细胞增强肿瘤特异性免疫。
J Clin Invest. 2020 Jul 1;130(7):3865-3884. doi: 10.1172/JCI131859.
7
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion.谷氨酰胺阻断诱导了不同的代谢程序来克服肿瘤免疫逃逸。
Science. 2019 Nov 22;366(6468):1013-1021. doi: 10.1126/science.aav2588. Epub 2019 Nov 7.
8
Medulloblastoma in the age of molecular subgroups: a review.分子亚组时代的髓母细胞瘤：综述
J Neurosurg Pediatr. 2019 Oct 1;24(4):353-363. doi: 10.3171/2019.5.PEDS18381.
9
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.在考虑分子亚组因素后髓母细胞瘤切除范围的预后价值：一项回顾性综合临床与分子分析
Lancet Oncol. 2016 Apr;17(4):484-495. doi: 10.1016/S1470-2045(15)00581-1. Epub 2016 Mar 12.
Zotero 插件